Literature DB >> 15184706

Patients with carcinoid syndrome exhibit symptoms of aggressive impulse dysregulation.

Sascha Russo1, Jim C Boon, Ido P Kema, Pax H B Willemse, Johan A den Boer, Jakob Korf, Elisabeth G E de Vries.   

Abstract

OBJECTIVE: Carcinoid tumors can produce excessive amounts of biogenic amines, notably serotonin. We assessed psychiatric symptoms in carcinoid patients and peripheral metabolism of tryptophan, the precursor of serotonin.
METHODS: Twenty consecutive patients with carcinoid syndrome underwent a structured psychiatric interview applying DSM-IV (Diagnostical Statistical Manual) criteria. Tumor activity was measured by determination of 24-hour urine excretion of 5-hydroxyindoleacetic acid (5-HIAA) and platelet serotonin levels. Plasma tryptophan levels were measured and compared with sex- and age-matched references.
RESULTS: Fifteen patients (75%) fulfilled diagnostic DSM-IV criteria for a disorder of impulse control. Tryptophan plasma levels were lower in patients compared with controls (p =.031) and were correlated negatively with urinary 5-HIAA excretion (p =.001).
CONCLUSIONS: Impulse control disorders are prevalent in patients with carcinoid syndrome. The serotonin production by the tumor possibly decreases the tryptophan pool in the cerebrospinal fluid, which is the essential substrate for the production of brain serotonin as a pivotal neurotransmitter.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184706     DOI: 10.1097/01.psy.0000126204.97565.91

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  10 in total

1.  Neuroendocrine carcinoid cancer associated with psychosis.

Authors:  Izchak Kohen; Sascha Arbouet
Journal:  Psychiatry (Edgmont)       Date:  2008-06

Review 2.  Carcinoid-syndrome: recent advances, current status and controversies.

Authors:  Tetsuhide Ito; Lingaku Lee; Robert T Jensen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-02       Impact factor: 3.243

3.  Must antidepressants be avoided in patients with neuroendocrine tumors? Results of a systematic review.

Authors:  Elie Isenberg-Grzeda; Meredith MacGregor; Konstantina Matsoukas; Ngai Chow; Diane Reidy-Lagunes; Yesne Alici
Journal:  Palliat Support Care       Date:  2020-10

4.  The possibility of evidence-based psychiatry: depression as a case.

Authors:  Drozdstoy Stojanov; Jakob Korf; Peter de Jonge; Georgi Popov
Journal:  Clin Epigenetics       Date:  2010-11-30       Impact factor: 6.551

Review 5.  Complications from carcinoid syndrome: review of the current evidence.

Authors:  José Mauricio Mota; Luana Guimarães Sousa; Rachel P Riechelmann
Journal:  Ecancermedicalscience       Date:  2016-08-08

6.  Topological Organization of Metabolic Brain Networks in Pre-Chemotherapy Cancer with Depression: A Resting-State PET Study.

Authors:  Lei Fang; Zhijun Yao; Jianping An; Xuejiao Chen; Yuanwei Xie; Hui Zhao; Junfeng Mao; Wangsheng Liang; Xiangxing Ma
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

7.  Health-related quality of life, anxiety, depression and impulsivity in patients with advanced gastroenteropancreatic neuroendocrine tumours.

Authors:  Alexandra R Lewis; Xin Wang; Laurice Magdalani; Paolo D'Arienzo; Colsom Bashir; Was Mansoor; Richard Hubner; Juan W Valle; Mairéad G McNamara
Journal:  World J Gastroenterol       Date:  2018-02-14       Impact factor: 5.742

8.  Multicenter phase 2 trial of nintedanib in advanced nonpancreatic neuroendocrine tumors.

Authors:  Renuka V Iyer; Bhavana Konda; Christos Fountzilas; Sarbajit Mukherjee; Dwight Owen; Kristopher Attwood; Chong Wang; Orla Maguire; Hans Minderman; Sheryl-Ann Suffren; Karen Hicks; John Wilton; Robert Bies; Danielle Casucci; Diane Reidy-Lagunes; Manisha Shah
Journal:  Cancer       Date:  2020-06-11       Impact factor: 6.860

9.  Acute inflammatory bowel disease complicating chronic alcoholism and mimicking carcinoid syndrome.

Authors:  Piercarlo Ballo; Pietro Dattolo; Giuseppe Mangialavori; Giuseppe Ferro; Francesca Fusco; Matteo Consalvo; Leandro Chiodi; Francesco Pizzarelli; Alfredo Zuppiroli
Journal:  Case Rep Gastroenterol       Date:  2012-08-16

10.  Development and Validation of a Score for Screening Suicide of Patients With Neuroendocrine Neoplasms.

Authors:  Lili Lu; Yuru Shang; Dietmar Zechner; Christina Susanne Mullins; Michael Linnebacher; Xianbin Zhang; Peng Gong
Journal:  Front Psychiatry       Date:  2021-06-11       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.